Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Leventhal, L. J.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

UPDATE

Management of Fibromyalgia

right arrow Lawrence J. Leventhal, MD

7 December 1999 | Volume 131 Issue 11 | Pages 850-858

Despite extensive clinical study, there is no distinct consensus on the optimal management of fibromyalgia. The cause of fibromyalgia has not been clearly defined, but several mechanisms may be involved. Abnormalities in sleep patterns, muscle structure, and cerebral blood flow have been associated with the syndrome, but it is unclear whether a causal relation exists between these abnormalities and fibromyalgia. Recent evidence suggests that alterations in the metabolism and function of the neurotransmitters serotonin, norepinephrine, and substance P may contribute to the development of fibromyalgia. No pharmacologic agents are indicated specifically for the treatment of fibromyalgia in the United States, and most pharmacologic therapies show only limited success, although drugs that affect serotonin or norepinephrine at the receptor site (such as antidepressants or tramadol) seem to generate the most consistent results. Tricyclic antidepressants may diminish the sleep disturbance and pain caused by fibromyalgia, whereas selective serotonin reuptake inhibitors may be more useful for sleep and coexistent depression only. Among the commonly used analgesics, preliminary data suggest that tramadol may be useful for treatment of fibromyalgia pain and that trigger-point injections may be helpful. Controlled trials of anti-inflammatory agents have demonstrated little usefulness of these drugs, and oral opioids have not been studied for this condition. Miscellaneous agents, such as growth hormone, tropisetron or ondansetron, 5-hydroxytryptophan, {gamma}-hydroxybutyrate, and S-adenosyl- L-methionine, have also shown promising preliminary results, but their clinical roles remain to be defined. Nonpharmacologic interventions (such as exercise, biofeedback, and electroacupuncture) have likewise shown some success. Therefore, a multidisciplinary approach that includes both pharmacologic and nonpharmacologic strategies is recommended.

Author and Article Information
space

From Graduate Hospital, Philadelphia, Pennsylvania.

Grant Support: In part by an unrestricted educational grant from Ortho-McNeil Pharmaceutical.

Requests for Reprints: Lawrence Leventhal, MD, Graduate Hospital, Pepper Pavilion, Suite 801, 1800 Lombard Street, Philadelphia, PA 19146-1497.


Related articles in Annals:

Letters
Management of Fibromyalgia
Frederick Wolfe
Annals 2000 132: 1004. [Full Text]  

Letters
Management of Fibromyalgia
Arthur Huppert
Annals 2000 132: 1004. [Full Text]  

Letters
Management of Fibromyalgia
Norman Muilenburg
Annals 2000 132: 1004-1005. [Full Text]  

Letters
Management of Fibromyalgia
Hideto Akama
Annals 2000 132: 1005. [Full Text]  

Letters
Management of Fibromyalgia
Lawrence J. Cohn
Annals 2000 132: 1005. [Full Text]  

Letters
Management of Fibromyalgia
Lawrence J. Leventhal
Annals 2000 132: 1005. [Full Text]  



This article has been cited by other articles:


Home page
ptjournalHome page
L. Brosseau, G. A Wells, P. Tugwell, M. Egan, K. G Wilson, C.-J. Dubouloz, L. Casimiro, V. A Robinson, J. McGowan, A. Busch, et al.
Ottawa Panel Evidence-Based Clinical Practice Guidelines for Aerobic Fitness Exercises in the Management of Fibromyalgia: Part 1
Physical Therapy, July 1, 2008; 88(7): 857 - 871.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
A. S. Russell and S. L. Aaron
Opioids and chronic pain
Can. Med. Assoc. J., October 28, 2003; 169(9): 902 - 904.
[Full Text]


Home page
ptjournalHome page
C. L Schachter, A. J Busch, P. M Peloso, and M S. Sheppard
Effects of Short Versus Long Bouts of Aerobic Exercise in Sedentary Women With Fibromyalgia: A Randomized Controlled Trial
Physical Therapy, April 1, 2003; 83(4): 340 - 358.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. C. Steere
A 58-Year-Old Man With a Diagnosis of Chronic Lyme Disease
JAMA, August 28, 2002; 288(8): 1002 - 1010.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
F. Wolfe
Management of Fibromyalgia
Ann Intern Med, June 20, 2000; 132(12): 1004 - 1004.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
H. Akama
Management of Fibromyalgia
Ann Intern Med, June 20, 2000; 132(12): 1005 - 1005.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. Huppert
Management of Fibromyalgia
Ann Intern Med, June 20, 2000; 132(12): 1004 - 1004.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
N. Muilenburg
Management of Fibromyalgia
Ann Intern Med, June 20, 2000; 132(12): 1004 - 1005.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. J. Cohn
Management of Fibromyalgia
Ann Intern Med, June 20, 2000; 132(12): 1005 - 1005.
[Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1999 by the American College of Physicians.